Article | August 22, 2023

Ensure Product, Process And Patient Data Integrity And Traceability Throughout The BioPharmaceutical Lifecycle

Source: IDBS UK HQ

By David Brick, Senior Director, Data Science, IDBS

GettyImages-1279248902 data links

Growing support for personalized medicines, managing external manufacturing, and supply chain disruptions are increasing costs, complexity, and risks for the pharmaceutical and biotech (“BioPharmaceutical”) industry. Despite the integral value of CDMOs to drug innovation and production, ensuring data integrity across multiple organizations remains a significant issue that requires a solution.

A holistic approach to data management may be the only way for BioPharma companies to gain control at every step of the product lifecycle and build the foundation for lasting competitiveness. The cornerstone of this foundation is a cloud-based digital transformation creates an end-to-end, contextualized view of the whole product and patient lifecycle.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online